AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Claglid Met 30mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Proqol Healthcare

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Claglid Met 30mg/500mg Tablet

Metformin/Gliclazide 30mg/500mg tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse reactions include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are vital for hypoglycemia management. Alcohol consumption should be minimized due to its potential to exacerbate low blood sugar. Additional side effects may include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a possibility. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to evaluate blood cell counts and liver function are recommended.

Uses of Claglid Met 30mg/500mg Tablet

Diabetes mellitus type 2

Major Benefits of Claglid Met 30mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 30mg/500mg Claglid Met tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

Common Side effects of Claglid Met 30mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Claglid Met 30mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Claglid Met 30mg/500mg Tablets. Ingest each tablet whole; do not chew, crush, or fracture it. Administer this medication with food.

How Claglid Met 30mg/500mg Tablet works:

Each Claglid Met 30mg/500mg tablet combines gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and Claglid Met 30mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Claglid Met 30mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Claglid Met 30mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Claglid Met 30mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Claglid Met 30mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. For those with mild to moderate liver disease, initiation should be at a low dosage; however, the medication is unsuitable for patients with severe liver dysfunction.

What if you forget to take Claglid Met 30mg/500mg Tablet :

Should you forget to take your Claglid Met 30mg/500mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, forgo the missed tablet and resume your usual dosing regimen. Never take more than the prescribed dose.

Facts to Know About Claglid Met 30mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Claglid Met 30mg/500mg Tablet

Claglid Met 30mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Claglid Met 30mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claglid Met 30mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Claglid Met 30mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). While rare, this side effect is more likely in patients with kidney disease, older individuals, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Claglid Met 30mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Claglid Met 30mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Claglid Met 30mg/500mg tablets is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Claglid Met 30mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Claglid Met 30mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claglid Met 30mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Claglid Met 30mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This is a rare side effect, but risk increases with kidney disease, advanced age, or excessive alcohol consumption. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Claglid Met and seek immediate medical attention.
Prolonged use of Claglid Met 30mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Claglid Met 30mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Claglid Met 30mg/500mg tablets is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Claglid Met 30mg/500mg Ta...
72
MRP 88
18% off